| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| custirsen | clusterin messenger rna | NA | Clinical trial target | TTD , DGIDB | Malignant neoplasm of breast[MeSHID:D001943] Malignant neoplasm of brain[MeSHID:D001932] Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
21.22 | phase 3 | antisense oligonucleotide |
| custirsen | estrogen receptor alpha | small molecule | NA | drugbank | Malignant neoplasm of breast[MeSHID:D001943] Malignant neoplasm of brain[MeSHID:D001932] Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | investigational | unknown |
| custirsen | nuclear factor nf-kappa-b p105 subunit | small molecule | NA | drugbank | Malignant neoplasm of breast[MeSHID:D001943] Malignant neoplasm of brain[MeSHID:D001932] Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | investigational | unknown |
| custirsen | nuclear factor nf-kappa-b p100 subunit | small molecule | NA | drugbank | Malignant neoplasm of breast[MeSHID:D001943] Malignant neoplasm of brain[MeSHID:D001932] Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||